Product Name :
Desmedipham-d5
Description:
Desmedipham-d5 is the deuterium labeled 1-Methyl-3-((tetrahydrofuran-3-yl)methyl)urea.
CAS:
Molecular Weight:
305.34
Formula:
C16H16N2O4
Chemical Name:
Smiles :
[2H]C1=C(NC(=O)OC2=CC(=CC=C2)NC(=O)OCC)C([2H])=C([2H])C([2H])=C1[2H]
InChiKey:
WZJZMXBKUWKXTQ-LOOCXSPQSA-N
InChi :
InChI=1S/C16H16N2O4/c1-2-21-15(19)18-13-9-6-10-14(11-13)22-16(20)17-12-7-4-3-5-8-12/h3-11H,2H2,1H3,(H,17,20)(H,18,19)/i3D,4D,5D,7D,8D
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Desmedipham-d5 is the deuterium labeled 1-Methyl-3-((tetrahydrofuran-3-yl)methyl)urea.|Product information|Molecular Weight: 305.34|Formula: C16H16N2O4|Smiles: [2H]C1=C(NC(=O)OC2=CC(=CC=C2)NC(=O)OCC)C([2H])=C([2H])C([2H])=C1[2H]|InChiKey: WZJZMXBKUWKXTQ-LOOCXSPQSA-N|InChi: InChI=1S/C16H16N2O4/c1-2-21-15(19)18-13-9-6-10-14(11-13)22-16(20)17-12-7-4-3-5-8-12/h3-11H,2H2,1H3,(H,17,20)(H,18,19)/i3D,4D,5D,7D,8D|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: To be determined|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Methoxsalen} site|{Methoxsalen} Metabolic Enzyme/Protease|{Methoxsalen} Purity & Documentation|{Methoxsalen} Formula|{Methoxsalen} manufacturer|{Methoxsalen} Autophagy} |Shelf Life: ≥12 months if stored properly.{{Elvitegravir} web|{Elvitegravir} HIV Integrase|{Elvitegravir} Protocol|{Elvitegravir} Description|{Elvitegravir} custom synthesis|{Elvitegravir} Autophagy} |Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.PMID:35670838 |Drug Formulation: To be determined|HS Tariff Code: 382200|References:|Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.Products are for research use only. Not for human use.|
